US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 7.720
- -1.550-16.72%
Close Nov 15 16:00 ET
- 7.800
- +0.080+1.03%
Post 19:59 ET
418.30MMarket Cap-1974P/E (TTM)
9.090High7.710Low3.15MVolume9.010Open9.270Pre Close25.85MTurnover5.93%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High0.82P/B410.01MFloat Cap1.42052wk Low--Dividend TTM53.11MShs Float137.610Historical High--Div YieldTTM14.89%Amplitude1.420Historical Low8.214Avg Price1Lot Size
Emergent BioSolutions Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 156.17%153.7M | 141.52%47.5M | 65.98%-62.6M | -504.99%-206.3M | -65.41%32.1M | 181.08%60M | -633.33%-114.4M | -393.30%-184M | -110.65%-34.1M | -71.72%92.8M |
| Net income from continuing operations | 143.58%114.8M | -8.30%-283.1M | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -211.72%-263.4M | -363.48%-261.4M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M |
| Operating gains losses | -404.11%-44.4M | ---- | ---- | ---74.2M | ---13.9M | --14.6M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -5.71%26.4M | -13.37%28.5M | -19.36%27.9M | -12.70%125.1M | -17.09%29.6M | -13.04%28M | -26.07%32.9M | 11.97%34.6M | 15.75%143.3M | 22.26%35.7M |
| Deferred tax | 170.37%7.3M | 88.24%-200K | -159.57%-12.2M | 68.88%-8.9M | 90.39%-5.2M | -88.21%2.7M | -342.86%-1.7M | -347.37%-4.7M | -162.17%-28.6M | -219.16%-54.1M |
| Other non cash items | -84.85%-18.3M | 28.11%23.7M | 168.75%4.3M | 163.36%34.5M | 550.00%24.3M | -179.20%-9.9M | 374.36%18.5M | -23.81%1.6M | 45.56%13.1M | 93.86%-5.4M |
| Change In working capital | -0.30%65.6M | 244.19%205.9M | -170.08%-97.5M | -3,247.62%-70.3M | -74.09%42.8M | 196.34%65.8M | -593.20%-142.8M | 53.95%-36.1M | 98.55%-2.1M | 28.16%165.2M |
| -Change in receivables | 15.43%82.3M | 115.41%20.4M | -2,023.08%-50M | -118.29%-21.6M | 3.65%36.9M | 569.08%71.3M | -3,410.00%-132.4M | -97.23%2.6M | 829.01%118.1M | -63.86%35.6M |
| -Change in inventory | -17,900.00%-18M | -324.14%-13M | 85.34%-4.5M | 101.05%600K | -43.98%25.6M | 99.63%-100K | 122.83%5.8M | 38.72%-30.7M | 14.26%-57.1M | 631.40%45.7M |
| -Change in prepaid assets | -2,640.00%-13.7M | 1,348.12%166M | -33.33%-6M | 158.79%11.7M | 108.33%30M | 96.64%-500K | -375.00%-13.3M | 72.89%-4.5M | -358.44%-19.9M | -76.96%14.4M |
| -Change in payables and accrued expense | 60.00%3.2M | 532.88%31.6M | -332.50%-34.6M | 31.90%-55.5M | -170.51%-42.2M | 125.64%2M | -118.34%-7.3M | 91.83%-8M | -1,098.53%-81.5M | -177.61%-15.6M |
| -Change in other working capital | 271.01%11.8M | -79.55%900K | -153.33%-2.4M | -114.36%-5.5M | -108.81%-7.5M | -122.58%-6.9M | 112.15%4.4M | 160.00%4.5M | 160.70%38.3M | 295.18%85.1M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 156.17%153.7M | 141.52%47.5M | 65.98%-62.6M | -504.99%-206.3M | -65.41%32.1M | 181.08%60M | -633.33%-114.4M | -393.30%-184M | -110.65%-34.1M | -71.72%92.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 692.59%112M | -101.79%-4.6M | 28.48%-10.8M | 155.68%212.3M | 74.89%-11.4M | 93.04%-18.9M | 902.80%257.7M | 53.11%-15.1M | -70.15%-381.3M | 0.87%-45.4M |
| Net PPE purchase and sale | 114.29%1.8M | 63.20%-4.6M | 28.48%-10.8M | 55.44%-51.6M | 51.69%-11.4M | 54.84%-12.6M | 61.06%-12.5M | 53.11%-15.1M | 48.33%-115.8M | 48.47%-23.6M |
| Net business purchase and sale | --110.2M | ---- | ---- | --270.2M | --0 | --0 | ---- | ---- | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | 97.63%-6.3M | --0 | ---- | ---- | ---- | ---265.5M | ---21.8M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 692.59%112M | -101.79%-4.6M | 28.48%-10.8M | 155.68%212.3M | 74.89%-11.4M | 93.04%-18.9M | 902.80%257.7M | 53.11%-15.1M | -70.15%-381.3M | 0.87%-45.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -319.30%-180.3M | 89.55%-50.9M | 487.62%40.7M | -211.33%-535.7M | -98.67%4.7M | -118.75%-43M | -1,485.99%-486.9M | 85.11%-10.5M | 441.28%481.2M | 420.42%353.1M |
| Net issuance payments of debt | -352.21%-194M | 90.83%-45.5M | 589.29%41.1M | -196.31%-543.4M | -98.83%4.1M | -118.68%-42.9M | -5,807.14%-496.2M | 1.18%-8.4M | 1,671.59%564.2M | 4,284.52%351.5M |
| Net common stock issuance | --9.3M | ---- | ---- | 110.23%8.4M | 200.00%200K | --0 | ---- | ---- | 22.55%-82.1M | 99.81%-200K |
| Proceeds from stock option exercised by employees | --13.4M | ---- | ---- | -64.00%1.8M | -75.00%500K | --0 | ---- | ---- | -68.55%5M | -41.18%2M |
| Net other financing activities | -8,900.00%-9M | -2,950.00%-6.1M | 80.95%-400K | 57.63%-2.5M | 50.00%-100K | 66.67%-100K | 50.00%-200K | 58.00%-2.1M | 60.67%-5.9M | -120.00%-200K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -319.30%-180.3M | 89.55%-50.9M | 487.62%40.7M | -211.33%-535.7M | -98.67%4.7M | -118.75%-43M | -1,485.99%-486.9M | 85.11%-10.5M | 441.28%481.2M | 421.00%353.1M |
| Net cash flow | ||||||||||
| Beginning cash position | -19.86%71M | -81.64%79M | -82.62%111.7M | 11.50%642.6M | -63.57%87.8M | -75.27%88.6M | -1.33%430.2M | 11.50%642.6M | -7.27%576.3M | -40.35%241M |
| Current changes in cash | 4,594.74%85.4M | 97.67%-8M | 84.40%-32.7M | -905.02%-529.7M | -93.66%25.4M | 98.37%-1.9M | -338.27%-343.6M | -49.71%-209.6M | 246.55%65.8M | 132.44%400.5M |
| Effect of exchange rate changes | --0 | --0 | --0 | -340.00%-1.2M | -236.36%-1.5M | 210.00%1.1M | -185.71%-600K | 33.33%-200K | 266.67%500K | --1.1M |
| End cash Position | 78.13%156.4M | -19.86%71M | -81.64%79M | -82.62%111.7M | -82.62%111.7M | -63.57%87.8M | -75.27%88.6M | -1.33%430.2M | 11.50%642.6M | 11.50%642.6M |
| Free cash flow | 212.03%147.9M | 133.81%42.9M | 63.13%-73.4M | -72.05%-257.9M | -70.09%20.7M | 146.52%47.4M | -166.04%-126.9M | -186.47%-199.1M | -255.98%-149.9M | -75.49%69.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
